Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study

Naveen Pemmaraju, Jacqueline S. Garcia, Jalaja Potluri, Jason G. Harb, Yan Sun, Paul Jung, Qin Q. Qin, Srinivas K. Tantravahi, Srdan Verstovsek, Claire Harrison

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study'. Together they form a unique fingerprint.

Medicine & Life Sciences